VBI Vaccines Inc. announced that it has entered into a stock purchase agreement with returning investor Brii Biosciences Limited to issue 1 common share at an issue price of $3,000,00 for the gross proceeds of $3,000,000 on July 5, 2023. The Transaction is contingent upon the closing of a concurrent underwritten public offering for aggregate gross proceeds of at least $5,000,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 HKD | +6.42% | +11.54% | -49.12% |
Mar. 25 | Transcript : Brii Biosciences Limited, 2023 Earnings Call, Mar 25, 2024 | |
Mar. 22 | Brii Biosciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1.16 HKD | +6.42% | +11.54% | 108M | ||
0.574 USD | -4.24% | -9.42% | 16.32M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.12% | 108M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 2137 Stock
- News Brii Biosciences Limited
- VBI Vaccines Inc. announced that it expects to receive $3 million in funding from Brii Biosciences Limited